The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-(5-Amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)(1,2,3,4-tetrahydronaphthalen-1-yl)methanone ID: ALA4760132
PubChem CID: 162658307
Max Phase: Preclinical
Molecular Formula: C18H17N5O
Molecular Weight: 319.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(-c2ccccn2)nn1C(=O)[C@H]1CCCc2ccccc21
Standard InChI: InChI=1S/C18H17N5O/c19-18-21-16(15-10-3-4-11-20-15)22-23(18)17(24)14-9-5-7-12-6-1-2-8-13(12)14/h1-4,6,8,10-11,14H,5,7,9H2,(H2,19,21,22)/t14-/m0/s1
Standard InChI Key: CAVJGRPSJPRJNJ-AWEZNQCLSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
17.4815 -20.4380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4804 -21.2575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1884 -21.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8981 -21.2571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8953 -20.4344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1866 -20.0291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5992 -20.0248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3470 -20.3543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8915 -19.7450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4802 -19.0388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6816 -19.2118 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7045 -19.8273 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.8097 -18.2910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3268 -17.6317 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6221 -18.2024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0998 -18.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9089 -18.7786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2424 -18.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9452 -17.4562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7594 -17.3725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0924 -16.6268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6122 -15.9642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7953 -16.0522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4660 -16.7980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
5 7 1 0
9 12 1 0
10 13 1 0
13 14 2 0
15 13 1 6
15 16 1 0
15 19 1 0
16 17 1 0
17 18 1 0
18 20 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 319.37Molecular Weight (Monoisotopic): 319.1433AlogP: 2.68#Rotatable Bonds: 2Polar Surface Area: 86.69Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.02CX LogD: 4.02Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -1.16
References 1. Korff M,Imberg L,Will JM,Bückreiß N,Kalinina SA,Wenzel BM,Kastner GA,Daniliuc CG,Barth M,Ovsepyan RA,Butov KR,Humpf HU,Lehr M,Panteleev MA,Poso A,Karst U,Steinmetzer T,Bendas G,Kalinin DV. (2020) Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action., 63 (21): [PMID:33089691 ] [10.1021/acs.jmedchem.0c01635 ]